Low- and middle- income Medicare beneficiaries face increasing financial burden as employer coverage erodes.
Medicare beneficiaries are facing an increased financial burden as employer-sponsored insurance (ESI) erodes, according to a new issue brief from The Commonwealth Fund.
Economic pressure has caused fewer employers to offer supplemental coverage to their retired employees, and individuals on Medicare with low to middle incomes are shouldering the most burdensome annual premiums, which can be over $500 more than those eligible for Medicaid. Compared with Medigap coverage, it can be 4 times more. Beneficiaries with high incomes ($48,000 a year or more if single) were more likely to have supplemental employer coverage. If they are eligible for Medicare but still working, beneficiaries were also more likely to be covered by an employer plan.
The research was conducted using an analysis of the 2010 and 2016 Medicare Current Beneficiary Survey with 10,741 respondents in 2010 and 14,778 respondents in 2016. Beneficiaries were grouped by poverty level and reported annual income. Additionally they were grouped into 1 of 5 mutually exclusive categories: Medicare only, Medicaid, ESI, Medicare Advantage, and Medigap. If there was overlap, hierarchy was assigned using the same order.
“Medicare will serve a generation that has experienced little or no growth in real wages, a reduction of assets and savings through economic crisis, and loss of employer- provided pensions and retiree health benefits,” the authors wrote. “It is an urgent priority that policymakers reexamine the program’s benefits and financing to meet the needs of older adults.”
Michael Thompson, the president and chief executive officer of the National Alliance of Healthcare Purchaser Coalitions, said in an interview with The American Journal of Managed Care® that the healthcare safety net is incredibly fragile, and it’s starting to feel a huge weight.
“With the retirement of the Baby Boomer generation and the abandonment of retiree coverage by employers, the squeeze is on for the public safety net (Medicare and Medicaid),” Thompson said. “The financial projections for Medicare as it stands are not sustainable at the same time that a growing segment of the population is increasingly dependent on these benefits for health security.”
According to Thompson, the burden mostly rests on the retired poor. He said that even with economic bounce back, the trend of employers no longer offering health insurance to their retired employees will continue. The uncertainty of the Affordable Care Act (ACA)'s future also creates issues for the retired community, especially for those younger than 65 years.
“The affordability of that coverage has been sustained, in part, by means testing of premiums and the Medicaid expansion under ACA. This group would be particularly impacted if ACA were to implode or its provisions changed materially” Thompson said.
In order to be sustainable, the cost of healthcare costs needs to slow, and regulation needs to play a greater role, Thompson said.
“The cost sharing under traditional Medicare is high, uncapped and without supplemental coverage which can be significant,” Thompson said. "The path forward will likely include movement to greater means testing both for both premiums and cost sharing going forward."
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More